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Well .... I'm almost one quarter 
through my tenure as President. It 
seems the honeymoon period is finally 
over. 
Troika has begun to involve itself in 
issues effecting the Medical Staff and 
to evolve the proceedings of the 
Medical Executive Committee. I've 
reported our successes to you in 
previous issues of Medical Staff 
Progress Notes. Most recently, we've 
helped to broker some difficulties 
encountered with the incorporation of 
Respiratory Therapy into the Patient 
Centered Care model. While some 
work still remains, I think it's fair to 
say that some new optimism exists 
with regard to this issue on the part of 
therapists, nurses, physicians, and 
administration, alike. 
The single largest challenge to Troika 
is representing, unifying (where 
possible), and protecting this Medical 
Staff. I believe we are practicing in an 
era of unprecedented external 
pressures which continue to make our 
professional lives more difficult. For 
those of you who needed a little extra 
light reading, I'm enclosing a recent 
article which highlights potential 
conflicts which might result from new 
changes in the Medicare System. 
Some ofthe most immediate problems 
are right here at Lehigh Valley 
Hospital, however. Because of this, 
the Medical Executive Committee will 
discuss Alex Rae-Grant's committee 
work on Citizenship and Loyalty. The 
hope is that we can bring suggestions 
to the Board on what the staff feels 
would be a reasonable expectations 
and rewards system. I have to confess, 
I see no other issue which will 
consume a larger proportion of our 
time over the next 18 months. 
Here's to the work still to be done! 
c___------
Robert X. Murphy, Jr., MD 
President, Medical Staff 
Legislative Update 
Thanks again to those of you who 
attended the first quarterly meeting of the 
Medical Staff and extended such a fine 
welcome to Dr. Greco, President of the 
Pennsylvania Medical Society (PMS). 
As you can see from the attached letter, 
Dr. Greco was impressed by the 
audience's interest and concern. Dr. 
Greco is appealing to any member of our 
Medical Staff, who is not currently a 
member of the Pennsylvania Medical 
Society, to consider joining the Society. 
Increased membership can only 
strengthen our position as we continue to 
fight for Tort and CAT Fund reform, as 
well as other medical issues. I feel it's 
important to stress that the PMS has 
officially deunified from the AMA. No 
longer are members of the PMS required 
to be members of the AMA. 
Please support your State society. If you 
are interested, contact either Lou Eister, 
Executive Director, Lehigh County 
Medical Society, at 437-2288; Judd 
Mellinger-Blouch, Director of Marketing 
Tuberculosis Revisited 
Tuberculosis continues to be a threat in 
our community. Therefore, we must 
prevent a communicable patient from 
entering the hospital environ-ment 
without proper precautions. Early 
identification of patients potentially 
infected with TB is imperative to a well 
designed TB program. 
A TB self-screening tool was 
implemented in the outpatient clinics and 
the Emergency Department in July, 1996, 
to identify individuals who may be at risk 
for TB. For private patients, we are 
enlisting the support of the ADMITTING 
PHYSICIAN to communicate with the 
admitting areas that the patient is a RIO 
for the State Society, at 1-800-228-7823, 
or myself in the Medical Staff Office at 
402-8980. Remember, it is only by virtue 
of a strong, unified society that we will 
have the strength to be heard in 
Harrisburg! 
Robert X. Murphy, Jr., MD 
Chairman, Legislative Committee 
Lehigh County Medical Society 
and 
OMSS Representative 
Lehigh Valley Hospital 
Some concern has been raised 
regarding the availability of medical 
consults in urgent situations at 17th & 
Chew. Please be assured that urgent 
medical consultations are available at 
17th & Chew, 24 hours a day. Also, the 
L VPG-Medicine group has an attending 
physician or resident back-up covering 
the house at all times. 
If an urgent medical consultation Is 
required of the LVPG-Medicine group, 
please call402-1150. 
1B so that proper isolation precautions 
can be promptly initiated. The same 
consideration should be made for private 
patients directed to outpatient testing 
areas for x-rays, blood work, etc., if RIO 
TB contributes to the differential 
diagnosis. In these cases, sending the 
patient to the hospital with a mask would 
be appropriate. 
The Infection Control Department 
recognizes and appreciates all efforts 
made to comply with these measures 
intended to reduce the risk of 
Tuberculosis transmission to the patients 
staff and visitors in the Lehigh Valley 





Tamoxifen and Cataract Formation 
by David Prager, MD, Principal Investigator, NSABP 
Tamoxifen is a drug that is frequently 
used for the treatment of breast cancer 
in both the adjuvant and metastatic 
setting. Because so many patients are 
taking Tamoxifen, you may be asked 
by some of your patients what they 
should do concerning the recently 
observed "slight" risk of developing 
Tamoxifen associated cataracts. 
The following is a summary of 
recommendations from the National 
Surgical Adjuvant Breast Project 
(NSABP): 
• Although baseline eye 
examinations are not being 
required, it is valuable to 
determine the baseline level of eye 
pathology prior to starting 
Tamoxifen, partly to avoid 
associating visual changes with 
Tamoxifen when pre-existing 
conditions are present. 
• In the asymptomatic patient, 
regular eye exams at least every 
two years are sufficient. These 
exams should include careful 
evaluation of the lens and 
biomicroscopic evaluation of the 
retina. There are no specific 
diagnostic tests for monitoring 
early Tamoxifen-related visual 
changes, other than visual acuities. 
• In the presence of confounding eye 
pathology or other vision 
concerns, the frequency of exams 
should be increased accordingly by 
the patient's eye care provider. 
• The presence of a few intraretinal 
crystals (i.e., less than 1 0) in the 
absence of macular edema or a 
decrease in visual acuity does not 
warrant discontinuation of the 
drug. However, monitoring should 
be increased accordingly (i.e., 
every three to four months initially 
and up to every six months as per 
the eyecare provider). 
• Patients should be advised as to 
the increased risk of cataract 
development while taking 
Tamoxifen, but it should be noted 
that the magnitude ofthe risk is 
unknown. The risk is likely to be 
less than that observed for steroids 
which are widely used in 
medicine. Patients with cataracts 
should be advised that Tamoxifen 
may accelerate the progression of 
the cataract. There is no evidence 
to suggest that cataract surgery 
would be more problematic for 
these patients, should they develop 
vision impairment from these lens 
changes. 
If you wish to receive a copy of the 
entire NSABP letter which was 
distributed to oncologists and eye care 
professionals, please call the Clinical 
Trials Office of the John and Dorothy 
Morgan Cancer Center at 402-0636. 
The Central Document Processing 
boxes at Cedar Crest & 1-78 have been 
relocated from the hallway off the main 
lobby to the wall outside the Medical 
Staff Lounge on the first floor. The 
move was necessary to comply with 
JCAHO standards. 
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L VHHN to Offer Vitality Plus to Persons 50+ 
Staying healthy and active is key to program," said John Stavros, Senior ) 
getting the most out of life, and Vice President, Marketing and Public 
L VHHN will soon launch an exciting Affairs. "They gave us input on 
new program designed to help people everything from the name of the 
ages 50 and over do just that. program and the services included to 
the membership cost." 
Called Vitality Plus, the low-cost 
program, which debuts in early May, Vitality Plus is the first program of 
features many opportunities and this size and scope to be offered 
activities for individuals and couples, through physician offices and their 
from exercise classes and cooking affiliated hospitals in eastern 
seminars, to social galas and even Pennsylvania. It's among the first in 
dance lessons. Vitality Plus members the nation to integrate such a diverse 
also get discounts on prescriptions, array of benefits into one health and 
health care products, travel, dining and wellness package. 
hotel reservations, and many other 
products and services. The program's goal is to help 
physicians keep people well, active 
The program is available through and productive through a 
participating family practitioners and comprehensive package of health 
internists in cooperation with LVHHN education and wellness services, 
and other PennCARE hospitals hospital amenities, social activities, 
) throughout eastern Pennsylvania. and medical and lifestyle cost saving< 
According to physicians, having so For example, for a person at risk for 
many health an? wellness heart disease, there are exercise 
opportunities tailored to individual programs, nutrition classes, stress 
patients' needs is what makes Vitality reduction seminars and other resources 
Plus unique. ... available through Vitality Plus. If 
members have questions about 
"Vitality Plus is designed to help insurance claims, their prescriptions or 
people stay healthy and have fun long term care, Vitality Plus offers 
doing it," said Francis A. Salerno, qualified assistance. If an individual 
MD, Acting Chief, Division of wants to expand social opportunities 
Geriatrics. "The heart of the program and meet people, there are special 
really centers on ways to extend the events, a dining club and travel 
efforts of physicians in making a discounts. 
positive difference in the health of 
their patients." "Vitality Plus was created to appeal to 
different people with different needs," 
L VHHN physicians and consumers said Susan Hoffman, who directs the 
from Lehigh, Northampton and Bucks program. "But no matter what the 
counties played a role in developing reason is for joining, once you're a 
the program. "To ensure that Vitality member you open the door to a wide 
Plus will meet customer needs, we range of opportunities and value. And 
held focus groups where physicians 
and community members shaped the 
it's all in one resource." ) 





(Continued from Page 4) VItality Plus was developed by Lehigh Valley 
Hospital and Health Network, one of the top 40 
The cost of membership is also a key hospitals for geriatric care In the nation, 
advantage of Vitality Plus. At $20 per according to U.S. News and World Report. 
year for an individual or couple, 
VItality Plus members receive a members can save up to $550 comprehensive array of benefits ... 
annually. For example, all new 
members receive two months of free Health & Education 
exercise classes at community • Worklhopaand Hmlnars 
locations, discounts on eyewear and • VItality Plus newsletter 
• PrHc:rlptlon review pharmaceuticals, long-term care • Clllms and health plan counullng 
insurance at below-market rates, and 
much more. Hospital Amenities 
• Valet parking 
Vitality Plus will soon have a toll-free • Cafeteria privileges • Phonecard 
phone line --Vitality Link-- to keep • Medical emergency card 
members informed about classes, • Home care visit after hospitalization 
events or general health issues. 
Social Events 
People can call Vitality Link at (888) • Volunteer opportunities 
584-PLUS to find out if their doctor is • VItality galas 
a participating Vitality Plus physician • Dining club 
and receive a membership application. • Dance lessons 
Discounts 
Watch for advertisements about • Long-term care Insurance 
Vitality Plus on radio and television • Eye wear 
and in local newspapers. • Pharmacy 
• Hearing care 
• Travel 
• Medical equipment 
Grand Opening for Breast Health Services 
You are Invited to Take Time to Celebrate Life and the Grand Opening of 
Breast Health Servlcu. 
On Saturday, May 3, open hous11 will be held at both Breast Health Services Centers from 
1 0 a.m. to noon. Meet the Breast Health Services staff, tour the facilities, 
take part In educational workshops, and enjoy some light refreshments. 
The Breast Health Servlc11 Cantara are located at: 
• 1240 S. Cedar Crest Blvd. 
Suite 203 
and 
• 401 N.17th Street 
Sulte108 
Please Note: Mammogr~phy services are now available in the Breast Ht1/th Services Centers at the 
above locations; they are no longer available at Lehigh Valley Diagnostic Imaging. 
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Outsourcing of Bactigens 
Health Network Laboratories will no 
longer be offering bacterial antigen 
testing as an in-house study. 
Several factors were key in making 
this decision: 
• Multiple studies in the literature 
show that the sensitivity of the 
Bacterial antigens is 
approximately equivalent to that of 
a well-performed Gram stain. 
• There is a concern for false 
positives using bacterial antigens. 
In a 1995 study done by Duke 
University, 1 ,268 clinical samples 
(CSF, urine, and three other fluids) 
were tested with a panel of 
bacterial antigens (Streptococcus 
pneumoniae, 3 Neisseria 
meningitidis serogroups, 
Ilaemophilus injluenzae, and E. 
coli K1). Ofthese assays, 57 
(1.1 %) were positive. Of the 57 
positive, 31 (54%) were false 
positives. 
• There has been a decrease in the 
amount of Haemophilus injluenzae 
meningitis seen because of 
vaccination. 
• We looked at the six month period 
from April30, 1996 to October 30, 
1996 to evaluate our own data. 
155 specimens were tested, two 
were positive, one of the positives 
was considered a false positive for 
Streptococcus pneumoniae. 
In evaluating CSF for meningitis, 
review the other CSF screening tests, 
CSF protein, glucose, leukocyte count. 
Normal values for these tests are war ) 
- 0-5 cells/ul, protein 15-45 mg/ml, 
glucose 50-75 mg/dl. Meningitis will 
usually produce more than one 
abnormal CSF parameter including a 
positive smear. 
If a bacterial antigen is still wanted, it 
may be ordered and will be sent to a 
reference lab. The test can be ordered 
in one of the following manners: 
1. As a battery called "bacterial 
antigens" (includes all of the 
following individual tests) 
2. As the individual tests: 
• Hemophilus influenzae B antigen 
· Streptococcus pneumoniae antigen 
• Group B Strep antigen 
• N. meningitidis antigen (this includes 
Groups A, Y, C, W 135, and BIE. coli 
Kl) 
• N. meningitidis group BIE. coli K 1 
antigen 
If you have any questions regarding 
this issue, please contact Georgia 
Colasante, Technical Specialist, at 
402-5580. 
Mid Atlantic Pain Specialists, operating 
the Center for Pain Management, Is now 
participating with Aetna/US Healthcare. 
• • • • • 
Effective March 1, Affinity has been added 
to the Aetna/US Healthcare contract for 
physical, occupational, and speech 
therapy services. In addition, Affinity 
participates In the Aetna/US Healthcare 
Workers' Compensation Advantage 
Program. Primary care physicians have 
the option of selecting Affinity as their 








To schedule a brief, hands-on OVID 
training session, please call Barbara 
Jobst in the Health Sciences Library at 
402-8408. 
New Additions 
The following books have been 
purchased for the Health Sciences 
Library at 17th & Chew: 
Medical Emergencies in the Dental 
Office, 4th edition 
Author: Stanley Malamed 
Call No. WB 105 M236m 
Urogynecology and Urodynamics: 
Theory and Practice, 4th edition 
Author: D. Ostergard, et al. 
Call No. WJ 190 U78 1996. 
Congratulations! 
Michael W. Kaufmann, MD, 
Chairperson, Department of Psychiatry, 
was recently informed by the American 
Board of Psychiatry and Neurology that 
he passed the examination for 
certification of Added Qualifications in 
Geriatric Psychiatry. 
James G. McHugh, MD, Vice 
Chairperson, Department of Emergency 
Medicine, finished 18th overall in the 5K 
run at the 78th Annual American College 
of Physicians meeting in Philadelphia on 
March 23. The meeting was attended by 
7,000 of the most prominent doctors in 
the country. 
Thomas D. Meade, MD, Division of 
Orthopedic Surgery, Charles C. Norelli 
MD, Division ofPhysical Medicine/ ' 
The following books are now 
available in the Library at Cedar Crest 
& 1-78: 
Cecil Essentials of Medicine, 4th 
edition 
Author: Thomas Andreoli, et al. 
Call No. WB 115 C388 1997 
(Reference Section) 
Essential Skills In Clinical Medicine 
, Author: Charles Bardes 
Call No. WB 39 B245e 1996 
Differential Diagnosis of Infectious 
Diseases 
Author: David Schlossberg, et al. 
Call No. WC 100 S345d 1996 
Textbook of Rheumatology, Sth edition 
Author: William Kelley, et al. 
Call No. WE 544 T355 1997 (Volumes 
1 and 2 - Reference Section) 
Textbook of Surgery: The Biological 
Basis of Modern Surgical Practice, 
15th edition 
Author: David Sabiston 
Call No. WO 100 T3552 1997 
Rehabilitation, and Alexander D. Rae-
Grant, MD, Division of Neurology, 
recently set a US Masters swimming 
world record as three of four members of 
a 400 meter medley relay team. The 
foursome eclipsed a four year old record 
of 4 minutes and 21 seconds (previously 
held by a team from Baylor University) 
by two seconds in recording a new 
Masters world record of 4 minutes and 19 
seconds. Drs. Meade and Norelli will be 
competing in the US Masters National 
Championship in May in Seattle, Wash. 
Leonard A. Merlo, DMD, Division of 
Oral and Maxillofacial Surgery, has 
successfully met the requirements for 
board certification by the American 
~oard of ~ral and Maxillofacial Surgery 
m the spectalty of oral and maxillofacial 
surgery. 
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Papers, Publications and Presentations 
Mark D. Cipolle, MD, PhD, Associate 
Chief, Division ofTrauma/Surgical 
Critical Care, co-authored a paper, "Post-
trauma Thromboembolism Prophylaxis," 
which was published in the January issue 
of the Journal of Trauma. 
The February issue of the Journal of 
Trauma published the article, "Bilateral 
Renal Artery Thrombosis Secondary to 
Blunt Trauma: Case Report and Review 
of the Literature," which was authored by 
Paul Frassinelli, MD, Surgical Resident, 
Michael D. Pasquale, MD, Chief, 
Division ofTrauma/Surgical Critical 
Care, Craig R. Reckard, MD, Chief, 
Section of Transplantation Surgery, 
James J. Goodreau, MD, Associate 
Chief, Division of Vascular Surgery, and 
Gerald P. Sherwin, MD, Chief, Division 
of General Surgery. 
RobertS. Gayner, MD, Division of 
Nephrology, had an article published in 
the July, 1996 issue of Nephrology 
Dialysis Transplantation. The article, 
"Delayed Function Reduces Renal 
Allograft Survival Independent of Acute 
Rejection," evaluates the relationship of 
delayed allograft function to acute 
rejection and long-term survival of 
cadaveric allografts. 
Herbert L. Hyman, MD, Division of 
Gastroenterology, spoke to the 
Department of Family Practice at Warren 
Hospital on "Chronic Fatigue Syndrome 
and the Gut" on April 2. On April 8, he 
spoke to the Visiting Nurses Association 
in Pottstown on "Chronic Fatigue 
Syndrome." 
A research paper, "Challenges in the Use 
of a Medical Outcome Scale in a Mental 
Health Clinic," was accepted for 
presentation at the annual American 
Psychiatric Association Convention to be 
held in San Diego, Calif., May 23-27. 
The co-authors of the paper are Michael 
W. Kaufmann, MD, Chairperson, 
Department of Psychiatry, Thomas 
Waser, PhD, Director of Clinical 
Epidemiology, Department of Health 
Studies, and Susan D. WHey, MD, Vice 
Chairperson, Department of Psychiatry. 
Peter A. Keblish, MD, Chief, Division of 
Orthopedic Surgery, was the principal 
speaker at a Paris Knee Meeting, 
Journees Du Genou, on March 14 and 15. 
Dr. Keblisltmoderated sessions and 
presented topics on soft tissue 
approaches, patella controversies, and 
unicompartment replacement arthroplasty. 
The Paris Knee Meeting has become an 
annual event with over 200 participants 
from the French orthopedic societies. 
Dr. Keblish also performed total knee 
surgery at the Hospital Bizet with 
demonstrations and live surgery on a 
patient with complex valgus knee ) 
deformity, which is his subspecialty 
interest within total knee arthroplasty. 
Peter F. Rovito, MD, Division of 
General Surgery, and Paul Frassinelli, 
MD, Surgical Resident, co-authored 
"Laparoscopic Reversal of a Silicone-
Banded Gastroplasty" which was featured 
in the Minimally Invasive Surgery Series 
of the January issue of Surgical Rounds. 
Thomas Wasser, PhD, Director of 
Clinical Epidemiology, Department of 
Health Studies, presented a poster, 
"Associations of Chronic Fatigue with 
Functional GI Complaints," at the East 
Coast Chronic Fatigue and Immune 
Dysfunction Syndrome Medical 
Conference held at Wheeling Jesuit 
University, Wheeling, W.Va., on Apri14 
and 5. The poster was authored by 
Herbert L. Hyman, MD, Division of 





Upcoming Seminars, Conferences and Meetings 
Medical Grand Rounds 
Medical Grand Rounds are held every 
Tuesday from noon to 1 p.m., in the 
hospital's Auditorium at Cedar Crest 
& I-78. 
Topics to be discussed in May include: 
May 6 - Neurology 
May 13 - Physical Medicine & 
Rehabilitation 
May 20 - General Internal Medicine 
May 27- Geriatrics 
For more information, please contact 
Becky Sherman in the Department of 
Medicine at 402-8200. 
Department of Pediatrics 
In the Shadow of Illness: Parents 
and Siblings of the Chronically Ill 
Child will be presented by Myra 
Bluebond-Lan'gner, PhD, Professor of 
Anthropology, Rutgers University, 
Camden, NJ, on Friday, May 9. ... 
Pediatric MRI: Case Presentations 
will be presented by Elliot I. 
Shoemaker, MD, and Howard D. 
Rosenberg, MD, Department of 
Radiology/Diagnostic Medical 
Imaging, Lehigh Valley Hospital, on 
Friday, May 30. This presentation 
will be sponsored by Lehigh Magnetic 
Imaging Center (LMIC) who will also 
provide lunch for the program. 
There will be no conference on May 
23. 
The above conferences will be held at 
noon in the hospital Auditorium at 
17th & Chew. For more infonnation, 
contact Kelli Ripperger in the 
Department of Pediatrics at 402-2540. 
Psychiatric Grand Rounds 
The Department of Psychiatry will 
host a presentation by Dr. George 
DuPaul of Lehigh University. Dr. 
DuPaul is a nationally recognized 
expert in the field of Attention Deficit 
Hyperactivity Disorder. The 
presentation will be part of the Grand 
Rounds Series and will be held on 
Thursday, May 15, from noon to 1 
p.m., in the hospital's Auditorium at 
17th & Chew. 
For more information, contact Bruce 
Curry in the Department of Psychiatry 
at 402-2810. 
Correction 
The newly revised short form History and Physical 
for Ambulatory Surgery (MRD-60) is available for 
distribution through the hospital's Print Shop. It 
was incorrectly listed in last month's issue of 
Medical Staff Progress Notes as being available 
through the "Pick and Pack" system. 
These forms may be ordered through e-mail . 
Select Bulletin Boards, IL VH Forms, then choose 
·use• Photocopying Request Please fill in the 
form completely. If you do not have e-mail, MRD-
60 forms may be ordered by completing a 
photocopy request which is available through the 
Print Shop. For more information or to obtain 
photocopy request forms, please contact Grant 
Follweller in the Print Shop at 402-8562. 
Medical Staff Trivia 
Of the 812 members of the Medical 
Staff, the name, John, Is the most 
predominant first name with 44, 
followed by Robert as a close second 
with 41. 
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Call Park Instructions 
A. Recommendations for Call Park Usage 
1. Emergencies and/or priorities - Physician to physicians should be done for emergencies and/or 
priority calls. 
2. Paging from a car phone or from a place where a call back is not possible. 
3. Patient to Physician - Only when a call back is not possible. 
4. Not to be used by Physician's or Employee's families. 
5. Not to be used for personal reasons. 
B. Call Park Prefixes 
111- STAT Call 
222 - Call from a family member 
333 - Call from a hospital employee 
444 - Call from a patient 
666 - Call from a physician 
777 - Business call 
C. Call Park Retrieval 
1. Inside the Hospital 
a. Dial the last 4 digits of the call park number as indicated on the pager display. 
(The last 4 digits will always begin with 09.) 
b. Call is connected, begin the conversation. 
Example of a call park call from a physician: 
Pager display 666-402-0963 
Dial: 0963 
Begin conversation 
2. Outside the Hospital 
a. Dial402 plus the 4 digit call park number indicated on the pager display. 
b. You will hear a dial tone for approximately 3 seconds. 
c. When dial tone stops, wait for a connect with takes approximately 2 seconds. 
d. Call is connected. Begin conversation. 
Example of a call park call from a patient: 
3. Busy Signal 
Pager display 444-402-0963 
Dial: 402-0963 
Hear dial tone 
Hear silence for 2 seconds 
Connection made; begin conversation. 
a. If you receive a fast busy signal, all circuits are busy. Hang up and dial the call park 
number again. 
b. If you receive a regular busy signal, the caller has hung up. Call the Page Operator 








The Who's New section of Medical Staff 
Progress Notes contains an update of new 
appointments, address changes, status 
changes, etc. Please remember to update your 
directory and rolodexes with this information. 
Medical Staff 
Appointment 
Mary P. Fabian, MD 
Emaus A venue Family Practice 
(Domenic M. Falco, DO) 
1101 W. Emaus Avenue 
Allentown, PA 18103-5929 
(610) 797-2000 
FAX: (610) 791-5814 
Department of Family Practice 
Provisional Affiliate 
Status Change 
Jerome Dunn, MD 
Department of Pediatrics 
Division of Allergy 
From Active to Honorary 
Kenneth M. McDonald, MD 
Department of Surgery 
Division of Vascular Surgery 
From Active to Two Year Leave of Absence 
Address Change 
P. Denis Kuehner, DO 
Orefield Medical Center 
5074 Kernsville Road 
Orefield, PA 18069-2320 
Peripheral Vascular Surgeons, PC 
Victor J. Celani, MD 
James J. Goodreau, MD 
James L. McCullough, MD 
Kenneth M. McDonald, MD 
John F. Welkie, MD 
1259 S. Cedar Crest Blvd. 
Suite 301 
Allentown, PA 18103-6206 
Resignations 
Ruben A. Gonzalez-Florin, MD 
Department of Pediatrics 
Division of General Pediatrics 
(Allentown Pediatrics Association) 
David J. Hetzel, MD 
Department of Obstetrics and Gynecology 
Division of Gynecology 
Section of Gynecologic Oncology 
(Lehigh Valley Women's Cancer Center -
Gazi Abdulhay, MD) 
Luis F. Oxholm, DO 
Department of Psychiatry 
(L VPG- Psychiatry) 
Dean A. Ruble, DO 
Department of Medicine 
Division of General Internal Medicine 
(Whitehall Medical Center) 
Andrea C. Taroli, MD 
Department of Pediatrics 
Division of General Pediatrics 
(Pediatric Clinic) 
Allied Health Professionals 
Appointments 




(John J. Cassel, MD, PC - Dr. Cassel) 




(Cardiovascular Associates- Dr. Marcus) 




(Allentown Anesthesia Associates- Dr. 
Maffeo) 




(Cardiology Care Specialists- Dr. Rossi) 




(Cardiology Care Specialists - Dr. Rossi) 
(Continued on Page 12) 
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(Continued from Page 11) 
Change of Supervising 
Physician 




From Dr. Candio at Candio, Feldman, 
Kovacs, Guillard & Lakata to Dr. Ordway at 
InterValley Cardiology 
Resignations 




(Lehigh OB/GYN, PC - Dr. Lam) 




(John J. Cassel, MD, PC -Dr. Cassel) 
Guila Glosser, PhD 
Associate Scientific 
Psychologist 




(Center for Women's Medicine- Dr. Klasko) 




(InterValley Cardiology- Dr. Subzposh) 




(Allentown Anesthesia Associates- Dr. 
Maffeo) 




(Panebianco-Yip Heart Surgeons - Dr. 
Yeisley) 




(Lehigh Valley Pain Management- Dr. Khan) 




(ABC Pediatrics- Dr. Fugazzotto) 




(Marsha A. Gordon, DDS) 




(Harry W. Buchanan IV, MD) 




(Lehigh Valley Ophthalmic Associates, PC -
Dr. Listhaus) } 




(Michael D. Pasquale, MD) 
Death 




(ABC Pediatrics- Dr. Fugazzotto) 
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April 8, 1997 :;;~, MEDfCAL STAFF SERVICES 
LEHIGH VALLEY HOSPITAL 
Robert X. Murphy Jr., MD, President 
Lehigh Valley Hospital Medical Staff 
P.O. Box689 
Allentown, PA 18105-1556 
Dear Dr. Murphy: 
Thank you for the kind message of appreciation expressed in your letter dated 
March 13,1997. I have had the opportunity to speak to many groups in recent 
months. I can honestly say that nowhere did I receive a warmer welcome than at 
Lehigh Valley Hospital. 
You were correct when you wrote that I "may be heartened to learn" that several 
members of your medical staff expressed interest in membership. As you know, 
physician support of organized medicine is the linchpin to our future success. 
Without unity, we will not succeed in forging positive changes in our health care 
system. 
Would it be possible for you to forward the names of these physicians to either Lou 
Eister, Executive Director of the Lehigh County Medical Society (610-437-2288) or 
Judd Mellinger-Blouch, the Director of Marketing for the State Society (1-800-228-
7823) and copy me? Lou or Judd can then follow-up with these physicians, 
supplying them with the information they need to become members. 
Again, thank you for hosting me at Lehigh Valley Hospital and for your kind letter. 
Please let me know if there is any other way I can be of service. Keep up the good 
work, Bob. 
Victor F. Greco, MD 
President 
cld/p/lehighv 
cc: Louis L. Eister 













Week in healthcare 
By Jonathan Gardner 
Looming changes in Medicare's 
practice-expense compensation for-
mula for physicians could force hos-
pitals to adjust financial arrange-
ments with their medical staffs. 
Facing losses of up to 44% in their 
Medicare income, some surgeons 
may want to close their private of-
fices and sell their practices or ask for 
office space in the hospitals in which 
they operate. 
Meanwhile, higher payments for 
specialty procedures performed in 
physicians' offices may motivate 
doctors to reduce the number of ser-
vices they deliver in hospital outpa-
tient departments or freestanding 
surgical centers. 
"I think the incentives will be to 
take something into the office as 
much as possible, or if there's noth-
ing to take into the office, reduc~ 
those costs by changing their prac-
tices," said Randy Fenninger, co-
chairman of the Practice Expense 
Coalition, a group of specialty groups 
opposed to the change. 
"It really perversely affects any-
body who does a procedure outside 
of the office," said William Rich, 
M.D., secretary for federal affairs for 
the American Academy of Ophthal---
mology and a general ophthalmolo-
gist in Falls Church, Va. 
The fight, previously a dispute be-
tween primary-care doctors and spe-
cialists, has finally spilled intO' the 
hospital sector. 
Academic medical centers, which 
are intensive providers of specialty 
care, say the expected reductions in 
reimbursement for specialty services 
could dam the flow of dollars from 
their faculty practice plans to their 
teaching and research programs. 
Faculty practice plan revenues rep-
resented 33% of medical school rev-
enues in 1994-1995. 
"The worry is that the surgical spe-
cialties will be far less amenable to 
cross-subsidization to nonsurgical 
primary-care activities," said Robert 
D'Antuono, assistant vice president 
in the division of healthcarc affairs 
for the Association of American Med-
ical Colleges. 
The AAMC has joined many spe-
cialty groups in asking HCFA to delay 
implementation of the new compen-
sation formula so it can be refined. 
Practice-expense reimbursement 
represents about 41% of physi-
42 
Surgeons face changes 
Medicare fee adjustments will affect doc-hospital relations 
cians' Medicare revenues, which 
are expected to reach $30.7 billion 
in federal fiscal 1997. In 1995, 
Medicare represented nearly one-
fifth of all spending on physician 
services in the U.S., a share that is 
growing slowly. 
In late January, HCFA released. 
preliminary estimates on the effects 
of its change to so-called "resource-
As a result, HCFA plans to set high-
er practice-expense fees for routine 
services if they are delivered in an of-
flee than if they are delivered in hos-
pitals or other out-of-office settings. 
For instance, under one HCFA sce-
nario, practice-expense compensa-
tion for skin lesion trimming or re-
moval will be nearly twice as high in 
many cases if done in the physician 
Winners and losers in Medicare physician fee shifts 
HCFA has calculated which specialties can expect to see their Medicare 
income increase and which can expect decreases when it changes practice-
expense reimbursement from a historical charge basis to a resource-based 













ment, which will convert physicians' 
overhead compensation to a formu-
la resembling that of physicians' 
work compensation. Under a 1994 
law, the change to resource-based 
compensation must take place on 
)an. l, 1998. 
Practice-expense payments-which 
compensate physicians for the of-
fice staff, utility, rent and equip-
ment costs attributable to serving 
Medicare beneficiaries-previously 
had been based on historical 
charges. 
The new resource-based formula 
will cause steep drops in payments 
for some surgical specialties and 
small boosts for some primary-care 
specialties, according to HCFA's 
projections. 
That will occur because HCFA rea-
sons that hospitals and other institu-
tions assume many of the practice 
costs of procedures delivered in 
those settings, while the physicians 
themselves bear most of the costs of 
office-based services. 










office than if performed in a hospital. 
That will give an incentive for those 
specialists who have a choice to divert 
more procedures into an office set-
ting, even if, in some cases, it means 
purchasing expensive equipment. 
"To determine whether I'm going 
to move a procedure from a nonof-
fice setting to an office setting, or 
vice versa, is going to depend on an 
analysis of where I'm better off," said 
Lawrence Goldberg, director of na-
tional healthcare affairs for Deloitte 
& Touche in Washington. 
Those specialties dependent on 
invasive surgical procedures, how-
ever, won't be able to make such ad-
justments to their practices and face 
significant reductions in their prac-
tice-expense compensation. That 
loss of income could motivate them 
to reduce costs by closing offices 
and seeking space in hospitals, or to 
sell their practices to hospitals or 
health systems. 
In a letter to HHS Secretary Donna 
Shalala, Paul Ebert, M.D., director of 
Continued 011 p. 44 
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' Week in healthcare 
By Jonathan Gardner 
In trying to squeeze billions of dollars 
in savings from the Medicare program, 
President Clinton has dusted off a pro-
posal to cut payments to physicians on 
"high-volume" hospital staffs. 
The plan potentially could force 
some hospital executives to seek new 
ways to limit the volume of services 
their staff physicians provide. 
Coupled with HCFA's plans to 
change how Medicare pays doctors for 
their practice expenses, the budget 
provision may test hospital-physician 
relationships even further. 
The White House proposal is esti-
mated to save about $2 billion be-
tween 1998 and 2002. It would target 
hospital staffs that deliver at least 25% 
more services per hospital admission 
than the national median. Rural hos-
pital staffs could exceed the national 
median by 40% before they would be 
subject to the payment cuts. 
Under the proposal, which has ap-
peared in past White House balanced-
budget plans, HCFA would withhold 
15% of each Medicare payment to 
physicians on high-volume hospital 
staffs beginning in 2000. If the staff 
successfully collaborates to reduce its 
volume, the physicians would receive 
their payments, plus interest, at the 
end of the year. The goal is to increase 
physician efficiency. 
)urgeon~ continued from p. 42 
. ~e. American College of Surgeons, 
, i!aid · the 'shift ·in practice-expense 
· Compensation could cause Medicare 
payments for heart transplants to 
drop by 57%, for coronary artery by-
pass ·operations by 44%, and for 
brain surgery and hip replacement 
by40%,.,. . 
, · ·.Thaf explains the big losses in 
. MediCare . nvenues expected for 
such specialties as cardiac and tho-
racic surgery (See chart, p. 42). And 
those . big losses explain surgeons' 
new push to delay the effective date 
of the new compensation formula 
so HCFA can rework it. 
"There's no way that anybody can 
take elimination of a quarter of their 
reimbursement in one fell swoop," 
said Marie Michnich, senior associ-
ate executive vice president with the 
American College of Cardiology. 
"This takes $830 million out of car-
44 
Docs on cutting edge 
Proposal seeks efficiency via reduced Medicare payments 
The proposal is one of three physician 
payment reforms seeking a total of $7.4 
billion in savings over five years. 
The White House justifies it by citing 
studies that show even after accounting 
for severity of illness, teaching programs 
and the number of low-income benefi-
ciaries they treat, utilization at some. 
hospitals is unusually high. 
Although the plan wouldn't affect di-
rect Medicare hospital payments, it 
would force hospital executives to deal 
with some thorny management issues. 
Those issues include managing the 
utilization of relatively unorganized 
hospital staffs; keeping physicians from 
diverting their patients from a hospital 
HCFA has labeled high volume to one it 
hasn't; and accounting for the high vol-
ume that occurs at hospitals with re-
spected specialty programs, such as 
academic hospitals. 
"It's unnecessary micromanagement, 
and there's no evidence to suggest that 
there is abuse," said Stephen Cooper, a 
lobbyist representing the Healthcare As-
sociation of New York State. 
Unless hospitals directly employ a 
significant number of their staff physi-
cians, some provider group represen-
tatives said, they may find it difficult to 
force doctors to cut back on how 
many services they provide to 
Medicare beneficiaries. 
In particular, said James Bentley, se-
nior vice president for policy develop-
ment at the American Hospital Associ-
ation, hospitals may face the argument 
from physicians that any effort to 
clamp down on utilization ignores 
how ill their patients are and how 
many services they need. 
Yet hospitals also would feel com-
pelled to try to placate physicians in 
order to keep them from sending pa-
tients to other facilities. 
In forcing hospital executives to con-
front these issues, HCFA would be 
handing them responsibility for re-
straining the high volume of health-
care services their physicians provide, 
Bentley said. 
"The hospital becomes the heavy 
hand," he said. 
But some provider group represen-
tatives questioned how hospitals could 
achieve such a goal. 
"You tell me how hospitals are going 
to organize those physicians," said Brent 
Miller, vice president of public policy 
and political affairs at the American 
Medical Group Association. "What's a 
hospital to do? Deny admissions?" ) 
Specialists, meanwhile, worry tht .· 
would be unfairly burdened by the 
plan, which they say doesn't account 
for the quality of care delivered in 
some top-flight programs. Cl 
Association weighed in. · ·. . . 
. Th~ 'AMA repeated its call for a 
· ~delay. in the implementa-
.. dat~'.so HCFA and specialty 
. ; groups can work together to devel-
. · op a formula that will not "adverse-
,ly affect Medicare patients' access 
;,: to quality healthcare services." 
',\,;.: !Jie .primary-care specialties, 
':'however;(.argue that the current 
? payment formula is unfair to them . 
· ... · They sa•i the resource-based formu-
diologybeginningJan.l."; i.}a should ·take effect as planned 
In addition, the specialists ques- ' next year on an interim basis that 
tion HCFA's ·estimates of revenue·:·· can be refined. · 
implications because they varied' "It's much better to work toward 
widely on how much different spe- ··implementation under the current 
cialties would gain or lose under re- time frame rather than throwing up 
source-based compensation. our hands and saying the whole 
"We don't think this is refin- thing needs to be scrapped," said 
able," said Rich of the ophthalmol- Robert Doherty, vice president f, ) 
ogists group. governmental affairs and pubh ... 
In a letter to HCFA Administrator'· policy at the American Society of In-
Bruce Vladeck, the American Med- temal Medicine. o 
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I. POLICY 
POLICY NO: AD 6850.00 
SUBJECT: Adult Code Blue 
Procedures 
LVDI, MRI, Cancer 
center, 1210,1230, 
1240, 400 & 401 
EFFECTIVE DATE: September, 1996 
AREAS AFFECTED: All Departments 
PAGE: 1 of 3 
A. A procedure shall be established to assure the hospital Code Blue 
Team and Emergency Medical Service respond to cardiopulmonary 
arrests in the Lehigh Valley Diagnostic Imaging (LVDI), Magnetic 
Resource Imaging Center (MRI) and Morgan Center (ground and first 
floor areas) . 
B. EMS only shall respond to cardiopulmonary situations in the 1210 
(MOB I), 1230 (MOB II) 1240 (atrium and floors 2-4), 401 
(Allentown Medical Center) and 400 (Fairgrounds Medical Center) . 
Refer to Attachment A 
II. ~ 
} Hospital Code Blue Team personnel responding to cardiopulmonary arrest 
situations in LVDI, MRI and Morgan Center ground and first floor areas. 
) 
III. DIPINITJQNS 
ACLS - Advanced Cardiac Life Support. 
AMC - Allentown Medical Center 
CPR - Cardiopulmonary Resuscitation 
EMS - Emergency Medical Service. 
PMC - Fairgrounds Medical Center 
Hospital Personnel - includes, but is not limited to, all employees, 
medical staff, allied health professional staff, students, volunteers, 
and others engaged in any activities at the hospital, excluding patients 
and visitors (JCAHO) . 
LVDI - Lehigh Valley Diagnostic Imaging 
MC - Morgan Center 
MRI - Magnetic Resonance Imaging. 
IV. PROCEDURE 
Action Responsibility 
A. Code Blue in LVDI. MEI and Me--ground and 
lobby levels 
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1. Code Blue Procedure 
a. Perform CPR on victim as 
appropriate. 
Action 
b. Refer to the Code Blue 
Procedure, Adult cc & I-78, 
AD #6830.00 or EP# 
2. Notification of Code Blue 
Situations: 
a. Dial 555 and notify of the 
following: 
Adult Code Blue, Location 
(LVDI, MRI, MC--floor, suite 
number or specific designated 
area) 
b. Dial 911 and notify of the 
following: 
Adult code blue 
Location 
Suite or designated area 
Advise of need for ACLS 
ambulance 
c. Notify the following via 
pager simultaneously: 
Designated Medical Resident 
Anesthesia 
Nursing Supervisor/Triage Nurse 
Respiratory Care 
Designated Critical Care Nurse 
Pastoral Care 
d. Announce via public address 
System, "Adult Code Blue, 
the building and specific 
location." 
B. Code Blue Resources 
c. 
Refer to Attachment B. 
Post Code Response Follow-Up 
1. Refer to Attachment C. 
2. Provide a quarterly activity 
report to the following for 
review and approval: 
• Special Care Committee 
• Emergency Management 
Committee 
3. Review and approve summary report 
submitted as appropriate to assure 






Security Dept. Head 
Security-Dept. Head 
Security Dept. Head 
Affected Personnel 
Affected Personnel 
Code Blue Committee 
Chair 










POLICY AD#6850.00 PAGE 3 OF 3 
D. Response to MQB I (1210). MOB II (1230). Affected Personnel 
MC (1240--atrium. floors 2-4). 
AMC (401) and FMC (400)Refer to 
Attachment A. 
V. ATTACHMBNTS 
Attachment A, "EMS Response Areas" 
Attachment B, "Code Blue Resources" 
Attachment C, "Post Code" 
VI. DiSTR4BQTION 
VI 
Administrative Policy Manual 
Emergency Preparedness Policy and Procedure Manual 
President and CEO 
Title 
President. Medical Staff 
Title 
Date 
VIII.POL4CX RISPONS4BiLITY IN COORP+HATION WJTH: 
Critical Care Director Code Blue Committee 
Director, Environmental Health & Safety 
IX. RIFIRilfCIS 
JCAHO Accreditation Manual for Hospitals - 1993 
Advanced Cardiac Life Support - 1993 
Administrative Policy AD 6830.00 Code Blue Procedures-Adult-CC & I-78 
X. RIV4S40NS 
Hospital reserves the right unilaterally to revise, modify, review, 
rescind or alter the terms and conditions of this policy within the 




Origination: 1/84 Medical Executive Committee: ______ __ 
Last Review: 9/96 Management Committee: 








EMS RESPONSE AREAS 
Emergency Medical Services shall respond to cardiopulmonary situations in the 121 0 (MOB 1), 
1230 (MOB II), 1240 (atrium and floors 2 through 4, Cancer Center), 401 (Allentown Medical 
Center) and 400 (Fairgrounds Medical Center). 
The hospital Code Blue Team will not routinely respond to these designated areas. 
Designated office personnel shall dial 911, stating unresponsive patient and need ACLS 
ambulance, building site, floor and office number. 
CPR trained personnel shall begin CPR and continue until the ACLS Unit arrives. 
Page21 
ATTACHMENT B 
CODE BLUE RESOURCES 
LOCATION·. CODE TYPE UNIT.PERSONNEL· ··EQUIPMENT 
RESPONDING 
· .. 
LVDI,MRI ADUTT STU 1st Call · Code Cart in unit 
MICU/SICU 2nd 
Call + 
+ Portable equipment 
Emergency Medical from ambulance 
Services 
MORGAN ADULT STU 1st Call MC Multi-purpose 
CENTER, GROUND MICU/SICU 2nd area personnel 
& LOBBY LEVELS Call bringing cart 
+ ) 
+ Portable equipment 






Complete NSG-199, Rev. 2/94 Refer to AD#6830.00, Affected Caregiver 
Cardiopulmonary Resuscitation Record Page 4, Section IV, 
and forward to Critical Care Office, Paragraph G, #7, 17, 18 & 
JDMCC, Suite #405. 19. 
Complete ADM-03, Rev 3/94, L VH When concerns are Affected Caregiver 




) • notification 
Forward Completed Form ADM-03, Rev Concerns are reviewed Affected Caregiver 
3/94 to Department of Environmental and addressed 
Health & Safety, 1243SCC, Suite 3122 appropriately 
Review completed NSG-199, Rev 2/94 Clinical procedures done Code Blue Second 
and coordinate follow-up action as appropriately Review Sub-
required Committee 
Place Code Blue Response Procedure Critical Care Office 









POLICY NO: AD 6860.00 
SUBJECT: Code Purple 
EFFECTIVE DATE: January, 1997 
AREAS AFFECTED: L&D, PNU, 4S, 
Emergency, MBU 
PAGE: 1 of4 
I. POLICY 
This policy shall define the medical back-up policy for OB/GYN services at the 17th 
Street campus. Medical consultations will be readily available for these patients. 
II. SCOPE 
This policy shall apply to all hospital employees, medical staff and students. 
III. PROCEDURES 
} Procedures for the medical back-up of the following patient types: 
) 
1. Medically stable patients requiring consultation -
a. Physicians in the relevant speciality will be called by the attending 
physician at 17th Street, a resident or other staff. All consultations must 
be performed within 24 hours of request (or sooner if desired by the 
attending physician). It is the expectation of participating in the on-call 
rotations for specialty services that all physicians taking such call will be 
available to promptly meet the service needs of the 17th Street campus. 
2. Patients in cardiopulmonary arrest-
a. Patients who experience either a cardiac and/or a respiratory arrest will be 
managed according to the principles and procedures outlined in the 
existing code blue policy for the 17th Street campus. 
3. Newly admitted patients being transferred to the 17th Street via ambulance-
a. All admissions to the inpatient units at 17th Street who ·are admitted via 
ambulance will have their clinical status screened by emergency 
department personnel at 17th Street llrior to being transferred to the patient 
Page 25 
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care area. Patients with unstable vital signs will be detained and further 
assessed while in the emergency department. The patient's attending 
physician will be promptly notified of the patient's whereabouts and 
medical condition. The emergency medicine attending in conjunction with 
the attending of record at the 17th Street facility will jointly decide upon 
the further appropriate disposition of the patient. 
4. Medically unstable inpatients -
a. If an inpatient becomes medically unstable, a "code purple" will be 
called by the attending physician, the resident or other involved health 
professional at the 17th Street location. The criteria for "medically 
unstable" will be considered as a significant alteration in vital signs 
requiring prompt intervention for stabilization, but not meeting the criteria 
for code blue status (i.e., no cardiac or pulmonary arrest). The 
determination of "medically unstable" will be made at the discretion of 
the attending physician, resident or health professional at 17th Street on 
the basis of the "need for prompt medical assistance". 
b. To initiate a "code purple" situation, a member of 17th Street professional 
team will call the hospital operator "1199" and request a code purple be ) 
called. 
c. The hospital operator upon receiving code purple notification will notify 
the following individuals of code purple status: 
1. The General Medicine/Ward Medicine Attending on-call (Monday -
Friday, 0700 - 1 700 hours) 
2. The medical resident on-call for 17th Street (week nights after 
5:00 pm - 8:00 am the following morning and all day 
Saturday and Sunday) 
3. The attending anesthesiologist on-call for 17th Street 
4. The respiratory therapist on-call for 17th Street 
5. The triage nurse at Cedar Crest site who will contact the ICU nurse 
available on MICU/SICU at Cedar Crest site and the appropriate 
nursing supervisor on call for 17th Street site. 
6. The intensive care unit medicine attending on-call 
7. The emergency department attending at 17th Street 
d. Upon receiving the code purple notification the following individuals will 
directly report to the site of the code purple: attending anesthesiologists, 
respiratory therapists, chief OB/GYN resident, nursing supervisors, ) 
Page26 
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MICU/SICU nurse. The general medicine attending will call the floor to 
establish familiarity with the situation and proceed directly to the floor to 
personally evaluate the situation (0700 - 1700, Monday -Friday). The 
medical resident on-call will promptly go the floor when in-house (week 
nights after 1700 - 0800, etc). The medicine intensive care unit attending 
will call the floor and establish familiarity with the case and give advice to 
the on-site physicians concerning immediate medical management. 
e. Overall responsibility for the management of the patient lies first with the 
attending physician of record at the 17th Street site. If the attending 
physician is uncomfortable with this role, the attending anesthesiologist 
will assume responsibility for support of the patient's vital signs pending 
the arrival of the Ward Medicine Attending or medical resident on call. 
The General Medicine Ward Attending or medical resident on call will 
assume overall responsibility for the patient upon arrival. Further 
disposition of the patient will be at the discretion of the General Medicine 
Attending or medical resident on call and consultation with the Attending 
of record at 17th Street and the Intensive Care Unit Attending. 
f. Patients who require further stabilization may be transferred to the 
emergency medicine department at 17th Street prior to ultimate transfer to 
the Cedar Crest campus . 
. 
g. In the event of the lack of a timely response from the general medicine 
attending or medical resident on call , medically unstable patients may be 
transferred to the emergency medicine department for further evaluation 
stabilization an disposition. 
IV. DISTRIBUTION 
Administrative Policy Manual 
v. 
President & CEO 
Title Date 
Date 
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Vll. POLICY RESPONSIBILITY: IN COORDINATION WITH: 




Hospital reserves the right unilaterally to revise, modify, review, rescind or 
alter the terms and conditions of this policy within the constraints of the law, 
















A Service of LEHJSHVALLEY 
HOSPITAL 
Approval of New Chemistry Profiles 
New laboratory panels were approved by the 
American Medical Association (AMA) and 
accepted by the HealthCare Financing 
Administration (HCFA). New billing codes will 
be mandatory by January 1, 1998. Health 
Network Laboratories has decided to institute 
these new panels effective in early May. A 
few days before the go-live date, Health 
Network Laboratories will send everyone an 
) e-mail alert to that effect. 
) 
A small survey of the medical staff resulted in 
one continuing concern with our current 
panels -- ADD A BUN TO THE CHEM 611 
We had decided to institute this addition and 
fortunately the government agrees. They 
defined a Basic Metabolic Panel to be 
electrolytes, BUN, creatinine, and glucose. 
This profile will now be referred to as a Basic 
Metabolic Panel and should, therefore, be 
ordered as such. 
In addition, they allow an Electrolyte Panel 
(the traditional 4 ions) and a new Hepatic 
Function Panel A which includes Albumin, 
Total and Direct bilirubin, alkaline 
phosphatase, AST and ALT (6 tests). This 
profile will be available to be ordered as a 
Hepatic Function Panel A. 
A Comprehensive Metabolic Panel is new 
and almost identical to our inpatient profile. 
To be consistent, we will adopt the name 
Comprehensive Metabolic Panel and it will 
contain the following changes: replace AL T 
with AST, replace GGTP with alkaline 
phosphatase, and drop uric acid. As new 
changes occur with HCFA, we will keep you 
informed. 
Please remember that individual test orders 
are still highly recommended and are more 
easily medically justified than panels. 
Additionally, all tests ordered on Medicare 
must be medically necessary. Should profiles 
or panels contain medically unnecessary 
tests for the management of a specific 
patient, they should not be used. Rather, 
individual tests, each medically necessary, 
should be ordered. 
If you have any questions regarding these 
profiles, please contact Gerald E. Clement, 
PhD, Technical Director, Clinical 
Laboratories, at 402-5589. 
Page 29 
Laboratory Test Ordering 
Health Network Laboratories strives to 
provide the best quality service. When you 
order a test, we want to do the correct test 
and report the results in a timely manner. 
However, sometimes the test order script is 
unclear and uninterpretable. We try to clarify 
the test through a number of procedures 
including calling the ordering physician. This 
delays obtaining the correct specimen with 
inconveniences to both the patient and the 
physician. Secondly, if we interpret the test 
request incorrectly, the physician does not 
receive the expected results, and the 
laboratory is not reimbursed for the test. 
Please give your patients clear test request 
scripts. If you have any ideas that the 
laboratory can institute to help solve this 
problem, please contact Health Network 
Laboratories at 402-8150. 
In order to give you an idea of the unclear 
scripts that are received, each month we will 
publish a "Script of the Month." 
Following is this month's "Script of the Month" 
which was received in the outpatient 
laboratories: 
DRAW BLOOD AND SEND TO 
REFERENCE LABORATORY 
If you have any questions regarding this 
issue, please contact Gerald E. Clement, 
PhD, Technical Director, Clinical 
Laboratories, at 402-5589, or John J. Shane, 





, lEH!HVAILEY : 
HOSPITAL : 
) THERAPEUTICS AT A GLANCE 
The following actions were taken at the March- April -1997 Therapeutics Committee Meeting Maria Bar, Pharm.D., BCPS, Barbara Leri, 
Pharm.D., Howard Cook, R.Ph, BCNSP, FASHP 
rPA NOT SUPERIOR TO tPA 
Reteplase (rPA, Retavase, Boehringer 
Mannheim) is a new tissue plasminogen activator 
thrombolytic agent recently marketed for the 
treatment of acute myocardial infarction as a 
rival to tP A. rPA is administered as double 
bolus of 10 units each given 30 minutes apart. 
Early studies (Rapid I and Rapid II) showed 
higher rates of early reperfusion with rP A 
compared to accelerated or "front-loaded" tPA 
without an increase risk of complications. 
Results from GUSTO 3, a recent mega-trial of 
> 15,000 patients were recently presented at the 
American College of Cardiology Annual meeting. 





PROPHYLAXIS AT L VH 
) with 30 day mortality as the primary endpoint. 
On March 19, 1997, a subcommittee of the 
Therapeutics Committee met to discuss the 
current recommendations for VTE prophylaxis. 
The subcommittee was comprised of 
representatives from orthopedics, trauma, 
hematology/oncology, OB/GYN, pulmonary, 
internal medicine, pharmacy and finance. The 
current literature was reviewed regarding low 
molecular weight heparin, unfractionated heparin 
and warfarin utilized by the various disciplines. 
The following are the 
) 
After 30 days, 7.4% of patients given rPA died, 
compared to 7.2% on tPA. Statistically, no 
difference between the two agents was found. 
The Therapeutics Cardiology Subcommittee 
reviewed the available data as summarized 
below: 
Clinical trials to date fail to show 
superiority of rP A 
LVH's experiences to date with tPA 
No risk.;.vs-benefit advantage to add rPA 
to formulary 
The subcommittee recommended not to add rPA 
to the L VH formulary with the consensus 
agreement of the Therapeutics Committee. 
recommendations of the subcommittee for VTE 
prophylaxis: 










unfractionated heparin plus 
sequential compression devices 
(SCD) 
warfarin and/or low molecular 
weight heparin (only for high 
risk patients defined by VTE 
protocol) until able to take 
warfarin and SCD 
warfarin 
unfractionated heparin 
unfractionated heparin and 
current thrombotic regimens (Poor 
literature support for use 
of LMWH post intervention). 
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Presently, low molecular weight heparin is on the 
L VH formulary restricted to the high-risk trauma 
patients only. It was the decision of the 
subcommittee to maintain the current status of 
LMWH. The only exception would pertain to 
patients who would normally receive warfarin 
who are unable or very difficult to be 
phlebotomized in order to monitor INR' s for 
warfarin adjustment. For these rare patients, it 
must be clearly written on the physicians order . 
that the patient is unable to receive warfarin due 
to difficulty in blood draws. This explanation 
must accompany the order for the formulary low 
molecular weight, enoxaparin (Lovenox) 30mg 
SQ Q12H to be dispensed. 
The subcommittee felt additional, more 
persuasive literature was required prior to 
changing the current practice for VTE 
prophylaxis at LVH. 
The above information was discussed solely with 
regard to prophylaxis rather than treatment of 
VTE. Please note, the selection, doses and 
duration of therapy are significantly different in 
this setting compared to prophylaxis. 
This topic will be continually reviewed and 
revised by the subcommittee as more data 
becomes available. 
IV VERAPAMIL STILL FIRST-
LINEATLVH 
The Cardiology Subcommittee revisited the IV 
diltiazem (CardizemR) usage criteria initially 
developed in 1992. The subcommittee members 
were an agreement with the criteria as stated 
below: 
Criteria for Use: 
IV Diltiazem intermittent boluses and/or 
continuous infusion can be administered after 
meeting one of the following criteria: 
1. Failure of I. V. verapamil. 
Failure defined as inadequate HR control after 
a total cumulative IVP verapamil dose of 20mg 
followed by a continuous infusion of 
verapamil 1 Omg/hr x 1 hour. 
2. 
3. 
And/or Intolerance to a 5mg I. V. verapamil dose 
defined as: 
a. A decrease in systolic blood pressure of 
lOmmHg from baseline or < 90mmHg and 
symptomatic. 
OR 
b. New onset or worsening CHF signs and 
symptoms. 
OR 
c. Documented allergy to verapamil HCL 
Baseline symptomatic hypotension < 90mmHg 
requiring pressor agents or, EF .< 35% and/or 
PCWP ~ 20mmHg. 
**LV. Diltiazem will not be used as a p.o. 
substitute in NPO patients. 
There is an under utilization of IV verapamil 
infusions at L VH. Prescribers are encouraged to 
consider verapamil infusions rather than 
intermittent IV bolus for patients requiring heart 
rate control. The use of a constant infusion of 
verapamil may avoid the hypotension and wide 
range of ventricular heart rate responses 
frequently seen with repeated bolus doses. 
Several studies supporting the safety and efficacy 
of verapamil by continuous infusion have been 
published. The usual dosing regimen starts with 
a 5-l Omg IV bolus over at least 2 minutes 
followed by initiating a continuous infusion oft 
5mg/hour. Dose titration to control ventricular 
rate below 100 beats/minute should be done 
every 15-30 minutes at 2.5-5mg increments. 
There are no published guidelines regarding the 
maximum recommended rate and duration of 
infusion. Based on several case reports, the use 
of a continuous verapamil infusion appears to be 
safe when administered up to a rate of 
15mg/hour for a duration of 7 days. One case 
report published described the use of a verapamil 
infusion for 33 days without an adverse effect 
suggesting that durations longer than one week 




· REZULIN ARRIVES FOR 
YlANAGEMENT OF TYPE II 
DIABETES - AMARYL 
DEPARTS 
Troglitazone (RezulinR- Parke-Davis), a 
thiazolidinedione oral antihyperglycemic agent 
which acts by improving target cell response to 
insulin, has been approved for formulary 
inclusion at L VH. It improves sensitivity to 
insulin in muscle and adipose tissue and inhibits 
hepatic gluceneogeneiss. Troglitazone is not 
chemically or functionally related to the 
sulfonylureas, the biguanides or the 
alpha-glycosidase inhibitors. 
The mechanism of action of troglitazone is 
thought to involve binding to nuclear receptor 
(PP AR) that regulate the transcription of a 
number of insulin response genes critical for 
control of glucose and fat metabolism. It does 
not depend on insulin for its effect. It is 
~'Urrently approved by the FDA for use in 
.1tients with type II diabetes currently on insulin 
therapy whose hyperglycemia is inadequately 
controlled (HbA1c > 8.5%) despite insulin 
therapy of over 30 units per day given as 
multiple injections. A supplemental NDA for 
troglitazone as monotherapy and for combination 
use with sulfonylureas was submitted by the 
manufacturer in early February. 
Troglitazone therapy should be initiated at 200mg 
once daily, with a meal, in patients on insulin 
therapy. The current insulin dose should be 
continued upon initiation of therapy. For 
patients not responding adequately, the dose of 
troglitazone should be increased often 
approximately 2-4 weeks. The usual dose of 
troglitazone is 400mg once daily, with a 
maximum recommended daily dose of 600mg. It 
is recommended that the insulin dose be 
decreased by 10-25% when fasting plasma 
glucose concentrations decrease to less than 
120mg/ dL in patients receiving concomitant 
Is~tin and troglitazone. No dosage adjustment in 
patients with renal impairment is required - this 
may provide an advantage to those patients that 
are not appropriate candidates for Meftormin 
(GlucophageR). Troglitazone should be used with 
caution in patients with hepatic disease. 
Clinically significant drug interactions include: 
Concomitant administration of cholestyramine 
which reduces absorption of troglitazone by 70%. 
Troglitazone may decrease the effectiveness of 
combinations of ethinyl estradiol and 
norethindrone contraceptive therapies. 
Troglitazone may induce drug metabolism by 
CYP3A4 and this action should be taken into 
consideration when prescribing other agents 
which use this metabolic pathway (i.e. 
cyclosporine, tacrolimus). 
Adverse effects observed include headache, 
infection, pain, dizziness, asthenia and nausea. 
Two patients in the clinical studies developed 
reversible jaundice which was consistent with 
idiosyncratic drug reaction on liver biopsy. 
Troglitazone is available as 200mg and 400mg 
non-scored, film coated tablets. The 200mg 
tablets cost $2.84 each; the 400mg tablets, $4.36 
each. 
Glimipiride (AmarylR), an oral hypoglycemic 
agent approved for formulary in October 1996 as 
possessing advantages to existing 
sulfonylureas, was removed from formulary 
status due to minimal usage and unrealized 
advantage over existing formulary agents. 
COMING SOON ... A NEW 
ANTINEOPLASTIC ORDER 
SHEET 
A long awaited preprinted order sheet addressing 
chemotherapy, fluid replacement and pre and 
post antiemetic therapies has been devised. The 
order sheet will comprehensively include details 
regarding the patient's necessary demographics 
laboratory vascular access and investigational 
protocol information. 
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Through standardization of the order sheet, more 
consistent information can be relayed to all health 
care providers and possible medication errors can 
be avoided. Following, a short 1 month pilot 
evaluating the present antiemetic regimens use 
for different therapies, the order sheet will be 
distributed and utilized in the appropriate areas. 
PHYSICIAN ORDER SHEET 
CHANGE 
In December 1996 at the Therapeutics 
Committee, the comment at the bottom of the 
physician order sheet was reviewed. The 
comment originally read "Authorization is hereby 
given to dispense the generic or chemical 
equivalent unless specifically underlined by the 
physician. " This comment led to some confusion 
in dispensing, since many physician's may 
underline orders out of habit, rather than a 
requirement for the brand name product to be 
dispensed. In order to correct the 
misinterpretation of the statement the committee 
discussed alternatives and unanimously approved 
to change the statement to "Authorization is 
hereby given to dispense the generic or chemical 
equivalent unless specified as brand necessary by 
the physician." This statement was approved by 
the Therapeutics Committee and the information 
communicated to the Medical Executive 
Committee, via the Therapeutics Committee 
Minutes and appeared in the Physician's Progress 
News Letter. 
New physician order forms printed from this 
point on, will have this new statement on the 
bottom. Older forms which have already been 
printed and may take 1-2 years until review and 
reprinting, will remain in circulation, though the 
original statement will not be considered valid. 
The necessity to write "Brand Necessary" will be 
instituted starting July 1, 1997 after you have bad 
the opportunity to communicate the information, 
with your respective staff. 
If you have any questions or concerns, please 
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My Friend Jack: From the 
Pen of the Krank 




Principles, premise, practice and prediction. 
Underlying the topic of physician-assisted 
suicide lie assumptions and unwritten subtexts 
which need to be exposed to the light of day. 
By hiding behind principles, those standing 
against physician-assisted suicide make a firm 
boundary where greyness and uncertainty may 
really lie. Dr. Schick exposes the logic (or 
illogic) behind such a stance, taking a firm 
stand for providing a medical means of death. 
Dr. Lizza takes issue with the premise behind 
physician-assisted suicide. Procedural safe-
guards of any kind, he argues, will not prevent 
abuse of the legalization of physician assisted 
suicide. The principle may be legitimate, but 
the premise is flawed. 
The Krank decided to get a word in here 
too. Alluding to two who have practiced 
physician-assisted suicide, we are reminded of 
the difference between the kindly internist and 
the VW bus deathmeister. Those who practice 
physician-assisted suicide have forced us all to 
frankly assess the situation, none more brutally 
or candidly in practice than Kervorkian. 
Principles, premise, practice and prediction. 
Yet I will take the editorial liberty of predicting 
that physician-assisted suicide, if put into 
legislation, will not utterly change the prin-
ciples of medicine. Physicians will individually 
decide where they stand on the issues. Egre-
gious errors in the premise will be exposed in 
the media rapidly, glaringly and garishly. 
Dangerous trends in practice will be halted by 
the outrage of society and the probity of the 
profession. My prediction is that changes in 
such laws are unlikely (since we really do not 
like change), will not play out as predicted by 
their sponsors, and will be repealed rapidly if 
they fail. 
Why, after all, are we debating physician-
assisted suicide? What would lead someone to 
seek the end of life in such an unnatural way? 
Fear of suffering, fear ofloneliness, over-
whelming sadness, debt, pain, the burden of 
age, a passing whim; different reasons can be 
constructed and conceptualized. What we 
need as a tonic to physician-assisted suicide is a 
conversation on the reasons why we are 
considering such a death. Where have we 
failed as society and as a profession in succor-
ing suffering, lessening loneliness, and in 
general easing the sadness of death? How can 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 
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we, at the end of life, maintain the value of life 
to the end? Let's have a conversation about 
why we are discussing physician-assisted 
suicide, to understand the principles, premise 
and practice which we are about to undertake. 
Physician-Assisted Suicide 
from a Logical Point of V"1euu 
Theodore Shick Jr. 
Professor of Biomedical Ethics 
Muhlenberg College 
The question of physician-assisted suicide is 
not about whether it should be done, but 
about how it should be done. For there is 
widespread agreement that certain forms of 
physician-assisted suicide are morally permis-
sible. When a physician removes a feeding 
tube from a patient in accord with an advance 
directive, for example, he or she is assisting a 
suicide. The United States Supreme Court has 
deemed such actions legal, and the Council on 
Ethical and Judicial Affairs of the American 
Medical Association has declared them ethical. 
Removing patients from life-support apparatus 
is not the only way physicians assist suicide. 
According to Elizabeth Markson, Associate 
Director of the Boston Gerontology Center, 
"estimates suggest that as many as 70% of all 
deaths in hospitals [4200 of the 6000 per day] 
are preceded by ad hoc, often sub rosa, decisions 
to withdraw care1• "This form of assistance 
may not be as direct as removing a feeding 
tube, but it is assistance nonetheless." 
Passive euthanasia-withholding or withdraw-
ing medical care to put someone out of their 
misery-is generally considered morally 
permissible because it is not viewed as an act of 
killing. The physician doesn't directly bring 
about the patient's death; he or she simply lets 
the patient die. Active euthanasia-performing 
a lethal operation to put someone out of their 
misery-is morally problematic because it is 
unquestionably an act of killing. Not all killing 
is immoral, however. Killing in self-defense, 
for example, is not immoral. Is killing someone 
to end their misery immoral? There are good 
reasons for thinking that it is not. 
Some things are intrinsically evil, such as 
intense suffering. And some things are 
inherently wrong, such as causing or allowing 
people to suffer intensely for no good reason. 
This insight can be stated in the form of a 
principle: unnecessary suffering is wrong. 
This principle can be used to formulate the 
following argument for active euthanasia: 
1) Unnecessary suffering is wrong. 
2) Allowing passive but not active euthanasia 
promotes unnecessary suffering. 
3) Therefore, allowing passive but not active 
euthanasia is wrong. 
) 




How does allowing passive but not active 
euthanasia promote unnecessary suffering? 
Consider the case of someone who is about to 
have their feeding tube removed. The decision 
has been made to end their life. Instead of 
ending it as quickly and painlessly as possible, 
however, current practice demands that they 
be starved to death. Even if they are comatose 
or drugged and thus don't experience the pain 
of starvation, their friends and loved ones must 
endure the pain of watching them waste away. 
Is this really necessary? Wouldn't it be more 
humane, more moral-to give such patients a 
lethal injection? 
One can reasonably oppose active euthanasia 
only if one has a good reason for rejecting the 
foregoing argument. Since the conclusion 
follows from the premises, the only reason one 
can have for rejecting it is that one or more of 
it's premises is false. Premise 1 is generally 
considered to be self-evident or true by 
definition. In either case, the chance of finding 
a counterexample to it is not good. So those 
who object to this argument must reject 
premise 2. Specifically, they must show that 
the suffering brought about by not permitting 
active euthanasia is necessary. Some claim that 
it is necessary to prevent the medical profes-
sion from getting a bad name. If physicians 
trade the white coat of the healer for the black 
hood of the executioner, it has been argued, 
their image will suffer. But it's unclear that 
their image will suffer, and even if it will, it's 
unclear that the suffering produced will 
outweigh the suffering experienced by 
untreatable patients. 
It's doubtful that physicians who perform 
active euthanasia will be looked upon as 
executioners. It's more likely that they will be 
looked upon as angels of mercy. Trading the 
white coat of the healer for the white wings of 
an angel may not be such a bad trade. More-
over, it can be argued that allowing active 
euthanasia will actually improve the image of 
the physicifln. For at present, many people fear 
being hospitalized for a terminal illness on the 
grounds that physicians will not take their pain 
seriously and will force them into "a childlike 
state of helplessness, diapered, sedated, 
incompetent. "2 
Then there is the slippery slope argument 
which says that if we allow physicians to put 
people out of their misery by killing them, the 
next thing you know they'll be killing everyone 
they don't like. (After all, look what happened 
to the Nazis.) Although I've heard physicians 
take this line, it seems to represent an unrea-
sonably dim view of the medical profession. 
Moreover, I know of no scientific evidence to 
support the cause-effect relationship assumed 
by the slippery slope argument. The Nazi 
analogy is far too weak to have any probative 
value. In any event, a properly constructed 
law could keep such potential abuses to a 
minimum. 
2 9th Circuit Court Judge Stephen Reinhardt, in Washington v. Glucksberg, 96 C.D. 0. S. 1507. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Page37 
Legalizing physician-assisted suicide, however, 
does not require legalizing active euthanasia. 
For there is a compromise position that 
secures most of the benefits of active euthana-
sia while avoiding most of its burdens: allow 
physicians to prescribe a means of committing 
suicide (such as barbiturates) to competent 
patients who are incurably ill and suffering 
intolerably. Safeguards, such as second 
opinions, committee approval, etc., could 
insure that the prognosis is correct and that 
. . . . . . . . . . . . . . . . . . . . . . . . . 
Legalizing Aaaiatad-5uicida: 
Preble•••• vvith Premise 
John P. Lizza, Ph.D. 
Assistant Professor of Philosophy 
KutztfTI.lm University 
Physician-assisted death may not always be a 
bad idea, but its legalization is. While there 
may be some "best-case" scenarios in which a 
physician assisting in the death of a patient 
would be good, its practice on a large scale, 
even with the procedural safeguards that have 
been proposed, would likely result in many 
unnecessary, undesirable, and involuntary 
deaths. This cost is not outweighed by the 
benefits that might be derived in some 
the patient's suffering is not due to inadequate 
comfort care. Since patients themselves would 
administer the drug, physicians would not be 
cast in the role of executioner, and the incline 
on any slippery slope would not be very steep. 
It is not a totally ideal solution because it does 
not provide a way of ending the suffering of 
those who are paralyzed or unable to swallow. 
But it would alleviate much more unnecessary 
suffering than is now legally possible. 
. . . . . . . . . . . . . . . . . . . . . . . . ... 
particular cases 1• The likelihood of these 
deaths is apparent as soon as one begins to 
think of how radically indefinite and unrealis-
tic the procedural safeguards are. 
First, eligible patients would have to be 
"terminally ill." However, there is no generally 
accepted definition of terminal illness, and 
it is difficult, if not impossible, to predict 
accurately life expectancy. Although some 
states in their "natural death laws" have linked 
"terminal illness" to a life-expectancy of less 
than six months, such a prediction on the part 
of physicians will be a guess, at best, in many 
cases. Eligibility will thus rest on the subjective 
determination of individual physicians, and it 
is unrealistic to assume that physicians will get 
it right all or most of the time. It is also 
unlikely that physicians will be able to exclude 
) 
) 
1 See, for example, the "Oregon Death with Dignity Act,u reprinted in Hastings Center Report 25:3 (1995), p.39. ) 





consistently their own subjective evaluation of 
the patient's quality of life from their estimates 
of whether patients are "terminally ill" for 
purposes of assisting in their death. Thus, it is 
likely that some people will die unnecessarily 
or because of someone's else idea of what kind 
of life is acceptable. 
Second, the safeguards are supposed to ensure 
that the patient requesting assistance in dying 
understands the diagnosis and prognosis, is 
informed of all options, including pain control 
and comfort care, and is capable of making 
health care decisions and acting voluntarily. 
But this is unrealistic. Perhaps, in some cases, 
in which very knowledgeable physicians have a 
lot of time to devote to an individual patient, 
these safeguards could be met. However, in 
many other cases, they would not be met. 
How often in a clinical situation are patients 
informed of all options? Most physicians do 
not know all options, especially when it comes 
to palliative care. Must the patient's informed 
consent for assistance in dying be any more 
informed than the consent that is obtained for 
surgery or some other medical procedure? 
Presumably not. Either informed consent is 
obtained or it is not. However, anyone with 
any clinical experience knows that in actual 
practice how seriously the standard of 
"informed consent" is met varies from "the 
patient signed on the dotted line" to "the 
patient was truly informed." Confirmation 
by a consultant and repetition of the "con-
sent" is no guarantee. The patient may have 
just signed on many dotted lines. The 
problem is that there are no additional 
safeguards to ensure that a higher standard 
of informed consent would be met. Instead, 
it is likely that, just as in other clinical 
situations, how well patients meet the 
standard would vary. The result, of course, is 
that there will be involuntary deaths, and 
that puts us smack in the realm of homicide. 
Third, physician-assisted death would 
supposedly be restricted to patients who 
voluntarily request it. However, it would 
soon be followed by strong pressures to 
legalize aid in dying of incompetent patients 
who are unable to express their wishes. Just 
as we allow surrogates to decide to forgo 
treatment on behalf of incompetent patients, 
why continue to force life on patients just 
because they have now lost the capacity to 
ask physicians for aid in dying. 
The danger, of course, is that many incom-
petent people, who are often demented and 
unable to assert their own interests, will be 
vulnerable to unwanted death. While some 
states have enacted strong requirements of 
proof about the wishes and interests of 
incompetent patients before allowing 
surrogates to forego life-sustaining treat-
ment on their behalf, these requirements are, 
in fact, relaxed in day-to-day decisions about 
incompetents. In the vast majority of cases, 
there is no judicial oversight. Occasionally, 
ethics committees get involved, but the 
requirements of evidence and proof of the 
incompetent's wishes are much less rigorous 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
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than in a court of law. Concerns such as the 
cost of medical resources and the emotional 
and financial interests of families may enter 
into the decision and erode the requirement 
of proof about what patients would want. 
Moreover, these concerns have probably 
played a disproportionate role in decisions 
involving patients without strong family and 
financial support. It is not that these con-
cerns are illegitimate. ndeed, they are 
ethically relevant. However, they are being 
introduced surreptitiously and without the 
kind of scrutiny necessary to ensure that 
abuse has not occurred. 
Thus, while there may be no inherent moral 
distinction between active and passive 
euthanasia, there are good, practical, moral 
grounds for drawing a legal line at this point, 
viz., the prevention of further abuse. It would 
be naive to think that a surrogate's interests 
or idea of an acceptable quality of life, rather 
than those of a patient, have never deter-
mined the decision to forego treatment. 
Thus, we may have already given too much 
authority to families and other surrogates to 
forego life-sustaining treatment for incompe-
tents. Before we extend this power to include 
requests on behalf of incompetents for 
physician-assisted death, it would be better to 
ensure that surrogates are meeting the 
appropriate principles and procedural safe-
guards for decision-making in withdrawal and 
withholding care from incompetents. 
Fourth, laws should not discriminate or 
unfairly impact on vulnerable segments of 
society. However, no contr~ls are proposed as 
to how to ensure that this will not happen if 
physician-assisted death is legalized. Given 
how heath care resources are currently 
distributed in this country, legalizing physi-
cian-assisted death will unfairly affect those 
who are socially and economically disadvan-
taged. Just as costs adversely and dispropor-
tionately affect the quantity and quality of 
medical treatment that these people receive, it 
will adversely affect the kind of assistance in 
dying that they receive. For these people, who 
lack power and financial resources, it is even 
more likely that the procedural safeguards will 
not be consistently met. 
'Finally, some might object that if we followed 
this line of reasoning, it would prevent us from 
enacting any law, since it is impossible to 
ensure that any law receives one-hundred 
percent compliance. However, since abuse of 
laws governing physician-assisted death would 
constitute homicide, the state has a stronger 
obligation to ensure that these laws, as 
opposed to most other laws, would not be 
abused. We would need at least as stringent 
due process safeguards as those we currently 
have in place for capital cases. The problem is 
that no such safeguards have been proposed 
for physician-assisted death. Moreover, the 
state cannot give us this guarantee. The private 
nature and context in which these decisions 
would be made would prevent the oversight 
needed to meet the more stringent require-
ment of precluding abuse. 








My Friend ~ack: From 
the Pen of n.e Krank 
Carlos Gomez, M.D., a well-known opponent of 
physician-assisted suicide recently said in an 
interview that he prefers Jack Kevorkian, M.D., to 
Timothy Quill, M.D., on the question of physician-
assisted suicide. Gomez did not elaborate on 
why he came to this conclusion. Permit me to 
offer an independent confirmation of Gomez's 
judgment, with some reflections on what is at 
stake. 
Timothy Quill appears to all persons as a 
reasonable and caring physician. He makes an 
effort to know his patients and to understand 
what they need. He wants physician-assisted 
suicide only for patients who are competent and 
who have come to the considered judgment that 
they need to have the control in their hands on 
how they die. Thus Quill says that we should 
legalize the possibility of physician-assisted 
suicide. As he describes it, it would happen only 
in those cases where the physician knew the 
patient and had exhausted other methods of 
caring for the dying. In short, Timothy Quill puts 
a kindly face on physician-assisted suicide. 
Jack Kevorkian is different. His relationships with 
his "patients" are quite casual. He does not know 
them for an extended period of time. Indeed, 
there may be only one interview before 
Kevorkian assists them to their death. Unlike 
Quill, he does not seek an independent 
confirmation of their terminal diagnosis nor is 
there any persuasive evidence that he looks for 
evidence of treatable depression. According to 
some observers, he is so careless that he does 
not pick up on clues that would lead a reason-
able observer to believe that the patient was 
being pressured into requesting assistance in 
suicide. In short, Jack Kevorkian is the antithesis 
of Quill. Why do I prefer him? 
The preference for Kevorkian is a preference 
for candor in public policy discussion. Jack 
Kevorkian presents us with how physician-
assisted suicide is likely to be practiced in this 
country, should it become legal. Practitioners 
will specialize in what Jack Kevorkian calls 
"medicine." It will not be limited in the ways in 
which proponents of physician-assisted suicide 
presume that it can be. Patients desperate and 
depressed will seek the "help" of these physi-
cians. Note that even under the current legal 
situation, Jack Kevorkian still practices his art. 
Imagine the freedom he and physicians like him 
would enjoy under a different legal regime. 
The "blessing" of Jack Kevorkian is that he 
makes this abundantly clear. For that we 
should be thankful. Perhaps we might also be 
concerned. 
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Inform the Lehigh Valley 
Hospital Medical Staff and 
employees of Important 
Issues concerning the 
Medical Staff. Articles 
should be submitted to Janet 
M. Seifert, Physician 
Relations, Lehigh Valley 
Hospital, Cedar Crest & 1·78, 
P.O. Box 689, Allentown, PA 
18105-1556, by the 15th of 
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Seifert at 402·8590. 
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